XML 70 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities:      
Net loss $ (10,932,590) $ (14,984,321) $ (23,368,283)
Adjustments to reconcile net loss to net cash from operating activities:      
Depreciation and amortization 2,660,826 3,314,360 4,107,761
Share-based payment compensation 1,668,050 4,587,282 5,493,689
Non-cash professional services expenses 37,379 27,487 24,369
Restructuring costs 3,606,020 770,749 822,320
Payment of restructuring costs (2,300,005) (770,271) (702,276)
Realized gain on marketable securities (826) (905) 0
Impairment of cost method investments 0 10,725 41,780
Gain on sale of cost method investment (2,096,364) 0 0
Provision for returns and doubtful accounts (294,074) 357,301 120,992
Deferred income tax provision 110,203 (83,350) (160,434)
Changes in operating assets and liabilities:      
Accounts receivable 3,327,614 4,849,209 3,830,769
Prepaid expenses and other current assets 1,129,742 (889,278) (333,732)
Inventory (276,571) 1,126,188 (359,348)
Other assets (95,052) 31,837 48,135
Accounts payable (1,809,000) (101,784) 1,446,111
Accrued expenses and other long-term liabilities (11,758,230) (660,906) 8,550,746
Deferred revenue 5,887,953 (2,852,793) 3,576,167
Net cash (used in) provided by operating activities (11,134,925) (5,268,470) 3,138,766
Cash flows from investing activities:      
Sales of marketable securities 33,982,164 32,332,954 22,098,206
Purchases of marketable securities (31,527,129) (21,267,582) (24,101,138)
Proceeds from sale of cost method investment 3,000,000 0 0
Transfer to restricted cash 0 (750,000) 0
Purchases of property and equipment (1,536,167) (2,487,128) (2,220,380)
Capitalized software development costs (973,842) (461,555) (1,001,025)
Security deposits (244,814) (29,746) (48,238)
Purchase of intangible assets (128,122) (101,642) (127,890)
Net cash provided by (used in) investing activities 2,572,090 7,235,301 (5,400,465)
Cash flows from financing activities:      
Proceeds from exercise of stock options 697,500 738,184 920,106
Proceeds from issuance of Series A preferred stock, net of issuance costs 8,731,677 0 0
Net cash provided by financing activities 9,429,177 738,184 920,106
Effect of exchange rate changes on cash and cash equivalents (229,470) (311,241) (243,268)
Net increase (decrease) in cash and cash equivalents 636,872 2,393,774 (1,584,861)
Cash and cash equivalents, beginning of period 18,651,468 16,257,694 17,842,555
Cash and cash equivalents, end of period 19,288,340 18,651,468 16,257,694
Supplemental Disclosures:      
Cash paid/(refund received) for income taxes, net 95,593 688,167 1,221,294
Non-cash financing activities:      
Less: Accrual of preferred stock dividends $ 216,379 $ 0 $ 0